Zentalis Pharmaceuticals (ZNTL) Stock Price & Financial Analysis
Zentalis Pharmaceuticals Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Zentalis Pharmaceuticals
What is the current stock price for ZNTL?
As of the latest trading session, ZNTL stock trades at $3.54. The 52-week range is $1.13–$6.95, with a day range of $3.48–$3.65.
What is the P/E ratio for ZNTL?
The P/E ratio (Price-to-Earnings) for ZNTL is shown in the Key Statistics section. This valuation metric helps compare Zentalis Pharmaceuticals, Inc. to industry peers.
Does ZNTL pay dividends?
Zentalis Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for ZNTL?
Based on 1 analyst, the consensus for ZNTL is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of ZNTL?
Zentalis Pharmaceuticals's market capitalization is $254.4M, classifying it as a micro-cap company. Zentalis Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.